...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Name Confusion

got this back from Zen IR on the name confusion:

"........we are still looking into this"

this is in relationship to the TD & a couple others who have yet to make the change to all accounts.

this seems very odd to be taking so long to be straightend out??? What's the hold up???

Share
New Message
Please login to post a reply